Quantcast

Latest Merck Stories

2014-05-13 16:26:32

THOUSAND OAKS, Calif., May 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of data from the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) study in the Journal of the American Medical Association (JAMA). Results from the 12-week study, which evaluated 1,896 patients with high cholesterol, showed treatment with subcutaneous evolocumab (140 mg every two weeks or 420 mg monthly) in combination with...

2014-05-13 08:33:45

BUFFALO, N.Y., May 13, 2014 /PRNewswire/ -- Kinex Pharmaceuticals announces the addition of two key executives to its clinical leadership team reporting to Chief Medical Officer, Dr. Rudolf Kwan. Douglas Kramer MD joins Kinex as Vice President of Clinical and Regulatory Affairs and Jane Devane has joined Kinex as Director of Clinical Operations. Dr. Kramer adds significant regulatory and clinical risk management experience and was previously a Medical Officer for the United...

2014-05-06 17:08:14

Age and testing of hip bone mineral density (BDM) when postmenopausal women discontinue bisphosphonate therapy can help predict the likelihood of fractures over the next five years. Bisphosphonates can reduce the risk of hip and spine fractures. But recent concerns about safety issues, including osteonecrosis of the jaw, atypical femoral fractures and esophageal cancer, have increased interest in interrupting or stopping bisphosphonate therapy after several years of treatment. This study...

2014-05-06 08:36:14

RICHMOND, Va., May 6, 2014 /PRNewswire/ -- Global Genomics Group (G3), a life sciences company investigating biological networks that lead to the development of disease to identify novel diagnostic biomarkers and therapeutic targets, today announced the appointment of Harry "Chip" Davis, Jr., Ph.D., as chief drug development officer. Dr. Davis will be leading the drug discovery group together with Szilard Voros, M.D., co-founder and CEO of G3. "We are pleased that such an...

2014-04-29 08:34:05

BOSTON, April 29, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company") today announced financial results for the three-month period ended March 31, 2014. First Quarter 2014 Financial Highlights -- Total revenues grew 15% to $7.2 million compared to $6.3 million in the first quarter of 2013; -- Cash flow from operations increased to $0.9 million as compared with $0.7 million in the first quarter of 2013; -- Repurchased...

2014-04-28 08:32:30

Providers get a comprehensive view of the vaccination rate of their entire patient population through one screen within Practice Fusion's web-based electronic health record (EHR) platform SAN FRANCISCO, April 28, 2014 /PRNewswire/ -- Practice Fusion, the country's largest physician-patient community, today launched its Population Health Management offering in collaboration with Merck (NYSE:MRK), a global healthcare leader committed to increasing access to health care for patients through...

2014-04-28 04:21:06

SINGAPORE, April 28, 2014 /PRNewswire/ -- Moleac, a revenue-generating Biopharma company focused on stroke recovery, announced today the appointment of Mr Elmar Schnee as non-executive Chairman of the company. Elmar Schnee succeeds to Prof Marc Vasseur, co-founder of Moleac and first Chairman (2004-2013). Mr. Schnee was from 2011 - 2013 CEO of Cardiorentis in Zug, Switzerland. Prior to this, Mr. Schnee was General Partner and member of the Executive Board of Merck KGaA, responsible...

2014-04-25 08:28:05

ROCKLAND, Mass., April 25, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66(th )Annual Meeting, taking place from April 26 - May 3, in Philadelphia, PA. http://photos.prnewswire.com/prnvar/20121220/SF32295LOGO-b Data from 14 study assessments presented by EMD Serono or its affiliate, Merck Serono, the...

2014-04-23 08:31:57

Stage and Screen Star Shines a Spotlight on Better Blood Sugar Management With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J., April 23, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy and Golden Globe-winning actress S. Epatha Merkerson on America's Diabetes Challenge: Get to Your Goals, an educational program intended to encourage people with type 2 diabetes to...

2014-04-17 08:27:47

BOSTON, April 17, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on April 29, 2014, to discuss financial results of the first quarter ended March 31, 2014. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call as follows: Date: Tuesday, April 29, 2014 Time: 8:30 am EDT...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related